Blood pressure control in patients with type 2 diabetes and hypertension

Diabetes, Obesity and Metabolism

Volumn 4, Issue 2, 2002, Pages 81-88

  González Juanatey, José R ^a  

^a University Hospital of Santiago de Compostela   (Spain)

Author keywords

Hypertension; Treatment; Type 2 diabetes mellitus

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CAPTOPRIL; CHLORTALIDONE; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; ENALAPRIL; FELODIPINE; FOSINOPRIL; FUROSEMIDE; HYDROCHLOROTHIAZIDE; INSULIN; LISINOPRIL; METHYLDOPA; NIFEDIPINE; NISOLDIPINE; NITRENDIPINE; PLACEBO; PRAZOSIN; RESERPINE; UNINDEXED DRUG;

BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG CHOICE; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; HEALTH CARE COST; HUMAN; HYPERTENSION; INSULIN SENSITIVITY; KIDNEY DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; REVIEW; SIDE EFFECT; STROKE; UNITED STATES;

EID: 0036250068     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1326.2002.00165.x     Document Type: Review

References (36)

1. Prevalence of hypertension of newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications
2. Predisposition to hypertension and susceptibility to renal disease to insulin-dependent diabetes mellitus
3. Diabetes and hypertension: The bad companions
4. Left ventricular mass in diabetes-hypertension
5. Blood pressure, antihypertensive treatment and stroke risk
6. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
7. Tight blood pressure control and risk of macrovascular and microvascular complication in type 2 diabetes: UKPDS 38
8. Influence of diabetes and type of hypertension on response to antihypertensive treatment
9. The Sixth Report of the Joint National Committee on the prevention, detection, evaluation and treatment of high blood pressure
10. 1999 World Health Organization/International Society of Hypertension guidelines for the management of hypertension
11. Cost-effectiveness of the lower treatment goal (of JNC VI) for diabetic hypertensive patients
12. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: The Steno type 2 randomised study
13. Effect of antihypertensive treatment on kidney function in diabetic nephropathy
14. Rationale and design for the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
15. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone
16. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension
17. Calcium-channel blockers for hypertension: Uncertainty continues
18. Dihydropyridine calcium-channel blockers for the treatment of hypertensive diabetic patients
19. Outcome results of the Fosinopril versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM
20. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
21. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension
22. Subgroup analysis of the placebo-controlled Chinese trial on isolated systolic hypertension in the elderly
23. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension: Systolic Hypertension in the Elderly Cooperative Research Group
24. Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension
25. Antihypertensive drug therapy and insulin resistance
26. Treatment selection considerations for the hypertensive diabetic patient
27. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)
28. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus
29. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy
30. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
31. β-blockers continue to surprise us
32. Effect of angiotensin-converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial
33. High blood pressure and diabetes mellitus: Are all antihypertensive drugs created equal?
34. Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study
35. Health outcomes associated with calcium-antagonists compared with other first-line antihypertensive therapies: A meta-analysis of randomised controlled trials
36. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomised trials